Medicis Pharmaceutical – Amendment No. 1 to the Medicis Pharmaceutical Corporation Supplemental Executive Retirement Plan (November 9th, 2011)
This Amendment No. 1 (Amendment) to the Medicis Pharmaceutical Corporation Supplemental Executive Retirement Plan (the Plan) is adopted by Medicis Pharmaceutical Corporation, a Delaware corporation (the Company), as of October 6, 2011, with an effective date of June 1, 2011.
Medicis Pharmaceutical – COLLABORATION AGREEMENT by and Between UCYCLYD PHARMA, INC. And HYPERION THERAPEUTICS, INC. Dated August 23, 2007 (November 9th, 2007)
This COLLABORATION AGREEMENT is entered into this 23rd day of August 2007 (Effective Date), by and between UCYCLYD PHARMA, INC., a Maryland corporation, with its principal place of business at 8125 North Hayden Road, Scottsdale, AZ 85258-2463 (hereinafter referred to as Ucyclyd) and HYPERION THERAPEUTICS, INC., a Delaware corporation, with its principal place of business at 847 Sansome Street, 3rd Floor, San Francisco, CA 94111 (hereinafter referred to as Hyperion). Ucyclyd and Hyperion are sometimes referred to herein individually as a Party and collectively as the Parties.